• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司库奇尤单抗诱导的已治愈银屑病斑块处多发性黑子:病例报告及文献复习。

Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review.

机构信息

Institute of Dermatology, Guangzhou Medical University, Guangzhou, China.

Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, China.

出版信息

Dermatol Ther. 2021 Sep;34(5):e15048. doi: 10.1111/dth.15048. Epub 2021 Jul 7.

DOI:10.1111/dth.15048
PMID:34212464
Abstract

Psoriasis is a systemic inflammatory disease commonly associated with postinflammatory hyper- and hypo-pigmentation. Psoriasis-related cytokines such as IL-17 and TNF can contribute to these pigmentation changes by regulating both the growth and pigment production of melanocytes. Here, we present the first reported the case of a patient with a 10-year history of severe psoriasis vulgaris, who developed multiple lentigines in areas of resolved psoriatic plaques during anti-IL-17A antibody secukinumab.

摘要

银屑病是一种常见的系统性炎症性疾病,常伴有炎症后色素沉着过度和色素减退。银屑病相关的细胞因子,如白细胞介素-17(IL-17)和肿瘤坏死因子(TNF),可以通过调节黑素细胞的生长和色素生成来导致这些色素变化。在这里,我们报告了首例接受抗白细胞介素-17A 抗体司库奇尤单抗治疗的 10 年重度寻常型银屑病患者,在银屑病斑块消退区域出现多处雀斑样痣的病例。

相似文献

1
Secukinumab-induced multiple lentigines in areas of resolved psoriatic plaques: A case report and literature review.司库奇尤单抗诱导的已治愈银屑病斑块处多发性黑子:病例报告及文献复习。
Dermatol Ther. 2021 Sep;34(5):e15048. doi: 10.1111/dth.15048. Epub 2021 Jul 7.
2
Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy.使用乌司奴单抗治疗后,银屑病斑块消退区域出现多发性雀斑样痣。
Dermatol Online J. 2014 Apr 16;20(4):22338.
3
Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature.银屑病治疗中生物制剂诱发的局限于银屑病斑块的多发性雀斑样痣:1例病例及文献复习
Cutan Ocul Toxicol. 2015;34(3):262-4. doi: 10.3109/15569527.2014.959664. Epub 2015 Mar 25.
4
Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects.寻常型银屑病合并银屑病关节炎患者接受白细胞介素-17A 抑制剂治疗:权衡获益与不良反应。
Narra J. 2024 Apr;4(1):e207. doi: 10.52225/narra.v4i1.207. Epub 2024 Jan 1.
5
Appearance of lentigines in psoriasis patient treated with guselkumab.使用古塞库单抗治疗的银屑病患者出现雀斑样痣。
Dermatol Online J. 2019 Jan 15;25(1):13030/qt0pc0g809.
6
Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.使用依那西普治疗后,在消退的银屑病斑块中出现多发性雀斑样痣。
Dermatol Online J. 2008 Jan 15;14(1):11.
7
Multiple lentigines confined to a resolving psoriatic plaque.多个雀斑样痣局限于一个正在消退的银屑病斑块内。
Dermatol Online J. 2009 Oct 15;15(10):15.
8
Review of secukinumab-induced adverse events of special interest and its potential pathogenesis.司库奇尤单抗相关特殊关注不良事件及其潜在发病机制的综述。
Dermatol Ther. 2022 Aug;35(8):e15599. doi: 10.1111/dth.15599. Epub 2022 Jun 8.
9
Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab.在用阿达木单抗治疗的患者中,多发性雀斑样痣局限于正在消退的银屑病斑块。
Dermatology. 2008;216(3):279. doi: 10.1159/000113947. Epub 2008 Jan 24.
10
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.司库奇尤单抗抑制白介素-17A 可诱导银屑病的早期临床、组织病理学和分子缓解。
J Allergy Clin Immunol. 2019 Sep;144(3):750-763. doi: 10.1016/j.jaci.2019.04.029. Epub 2019 May 24.

引用本文的文献

1
Cutaneous Changes Beyond Psoriasis: The Impact of Biologic Therapies on Angiomas and Solar Lentigines.银屑病之外的皮肤变化:生物疗法对血管瘤和日光性雀斑的影响
Medicina (Kaunas). 2025 Mar 22;61(4):565. doi: 10.3390/medicina61040565.
2
Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress.逆转白发:通过毛发色素形成和再着色进展的研究为新疗法的开发带来启示。
Int J Biol Sci. 2023 Aug 28;19(14):4588-4607. doi: 10.7150/ijbs.86911. eCollection 2023.
3
Recurrence of psoriasis on the resolution sites left with lentiginous pigmented patches after TNF inhibitor therapy.
肿瘤坏死因子抑制剂治疗后,在遗留有雀斑样色素沉着斑的消退部位出现银屑病复发。
An Bras Dermatol. 2023 Nov-Dec;98(6):866-867. doi: 10.1016/j.abd.2022.04.015. Epub 2023 Jun 23.
4
A Review of the Safety of Interleukin-17A Inhibitor Secukinumab.白细胞介素-17A抑制剂司库奇尤单抗的安全性综述
Pharmaceuticals (Basel). 2022 Nov 7;15(11):1365. doi: 10.3390/ph15111365.